Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peptivet Oto
- Development stage
- Unknown
- Lead developer
- Nextmune
- Modality
- Peptides, Small Molecules
- Administration
- Topical, Otic
01
Overview
Peptivet Oto is a topical otic product line developed by Nextmune for the management of otitis and various ear conditions in companion animals, specifically dogs and cats. The formulation features a synergistic combination of AMP2041, a synthetic antimicrobial peptide, and Tris-EDTA. AMP2041 works by disrupting the cell membranes of ear pathogens, including bacteria and fungi, while Tris-EDTA enhances the permeability of bacterial cell walls to facilitate antimicrobial action. Beyond its antimicrobial properties, the product contains Zinc PCA, Vitamin PP (niacinamide), and GPI Lysine, which provide anti-inflammatory, moisturizing, and soothing effects to help restore the skin barrier and maintain the physiological balance of the ear canal. It is available in both gel and ear drop (solution) formulations for topical administration.
- Brand names
- Peptivet OtoPeptivet Oto Gel
- Other names
- Peptivet
Beyond the preview
Go deeper on Peptivet Oto.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Peptivet Oto.